OCRA
News & Updates
-
Ovarian Cancer Resources & Support
OCRA is committed to offering patients, caregivers and friends the most up to date information about ovarian cancer, helpful resources, and options for support…
-
FDA Approves Mirvetuximab Soravtansine-Gynx for Treatment of Platinum-Resistant Ovarian Cancer
In exciting treatment news, the Food and Drug Administration (FDA) has granted accelerated approval to mirvetuximab soravtansine-gynx (trade name Elahere, made by Immunogen, Inc…
-
Managing Diet for Ovarian Cancer
Many ovarian cancer patients and survivors wonder what the ideal diet for ovarian cancer may be. In a nutshell – there is no simple answer…
-
Ovarian Cancer from Beyond the Ovary: Perspectives on Science, Clinical Progress & Advocacy
“I don’t believe we can maximize our impact on ovarian cancer without embracing opportunities in other gynecologic cancers.” Dr…
-
Giving Tuesday is #GiveHopeTuesday
Personal stories have power. And simply by sharing your story on social media, you can raise important funds to support OCRA’s fight against ovarian cancer…
-
The Overview: November 2022
As we approach the time of year when we reflect on all that we are thankful for, we at OCRA are grateful for you — our incredible community — who support us…
Help Save Women's Lives
Our Impact
-
Invested over $100M
in ovarian cancer research since 1998
-
Educated 95,000+
future medical professionals since 2002
-
Advocated for $200M+
in government research and education funding in 2019
Fundraise for OCRA
-
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
-
Ovarian Cycle
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!